Dave Young
Overview
Explore the profile of Dave Young including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Young D, Bartlett L, Guimbellot J, Milinic T, Burdis N, Gill E, et al.
J Cyst Fibros
. 2023 Oct;
23(3):545-548.
PMID: 37798159
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, including elexacaftor/tezacaftor/ivacaftor (ETI), significantly improve outcomes and quality of life for people with cystic fibrosis (CF). However, little is known about how lung...
2.
Schuster S, Arora S, Wladyka C, Itagi P, Corey L, Young D, et al.
Cell Rep
. 2023 Jul;
42(8):112840.
PMID: 37516102
3' untranslated region (3' UTR) somatic mutations represent a largely unexplored avenue of alternative oncogenic gene dysregulation. To determine the significance of 3' UTR mutations in disease, we identify 3'...
3.
Zhang J, Busse M, Wang S, Young D, Mattson K
Sci Total Environ
. 2022 Sep;
854:158742.
PMID: 36108872
Losses of C and N from the forest floor and top 20-cm of soil were estimated following separate severe wildfires at two Long-Term Soil Productivity sites in the Sierra Nevada...
4.
Reeve A, Moghaddam N, Tickle A, Young D
Clin Psychol Psychother
. 2021 Jan;
28(5):1001-1019.
PMID: 33469958
Purpose: Recent intervention research for burnout amongst those working in health and social care contexts has found acceptance and commitment therapy (ACT) interventions to be of use but has provided...
5.
Kapnadak S, DiMango E, Hadjiliadis D, Hempstead S, Tallarico E, Pilewski J, et al.
J Cyst Fibros
. 2020 Mar;
19(3):344-354.
PMID: 32115388
Background: Advanced cystic fibrosis lung disease (ACFLD) is common, is associated with reduced quality of life, and remains the most frequent cause of death in individuals with cystic fibrosis (CF)....
6.
Asche C, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, et al.
Int J Chron Obstruct Pulmon Dis
. 2012 Apr;
7:201-9.
PMID: 22500120
Background: To estimate the potential cost savings by following the current Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline recommendations in patients being treated for chronic obstructive pulmonary disease...
7.
Fox N, Kaiser-Weiss A, Schmutz W, Thome K, Young D, Wielicki B, et al.
Philos Trans A Math Phys Eng Sci
. 2011 Sep;
369(1953):4028-63.
PMID: 21930564
The Earth's climate is undoubtedly changing; however, the time scale, consequences and causal attribution remain the subject of significant debate and uncertainty. Detection of subtle indicators from a background of...
8.
Gupta S, Maitra R, Young D, Gupta A, Sen S
Am J Physiol Heart Circ Physiol
. 2009 Jun;
297(2):H627-36.
PMID: 19502558
Myotrophin-induced activation of NF-kappaB has been shown to be associated with cardiac hypertrophy (CH) that progresses to heart failure (HF). In the present study, we examined the cause-and-effect relationship between...
9.